Rhodiola in particular has research supporting its use for fatigue
Why Combination Treatment Matters One of the most interesting findings from the new data is that sequencing appears important
Metabolism & Elimination GLP2 undergoes metabolism through pathways typical of peptide therapeutics: Plasma half-life of approximately 5 days in humans, enabling once-weekly administration Primary metabolic pathways include proteolytic cleavage of the peptide backbone, beta-oxidation of the C20 fatty diacid moiety, and amide hydrolysis Not metabolized via cytochrome P450 enzymes, sulfation, or glucuronidation pathways Low potential for drug-drug interactions mediated through hepatic metabolism or transporter systems The extended half-life represents a key pharmacokinetic advantage, with steady-state accumulation of approximately 1.7-fold enabling consistent therapeutic exposure throughout the dosing interval
Supplementary Information Additional file 1: (download DOCX Figure S1
a non-GLP-1 agonist show that overall, thyroid cancer is increased in people who take GLP-1s
Quarterly check-ins after the first year After 12 months, if your weight has remained stable, you can likely shift to quarterly monitoring
